Details for New Drug Application (NDA): 216791
✉ Email this page to a colleague
The generic ingredient in FOMEPIZOLE is fomepizole. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fomepizole profile page.
Summary for 216791
Tradename: | FOMEPIZOLE |
Applicant: | Gland Pharma Ltd |
Ingredient: | fomepizole |
Patents: | 0 |
Suppliers and Packaging for NDA: 216791
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 216791 | ANDA | Sagent Pharmaceuticals | 25021-829 | 25021-829-02 | 1 VIAL in 1 CARTON (25021-829-02) / 1.5 mL in 1 VIAL |
FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 216791 | ANDA | Gland Pharma Limited | 68083-510 | 68083-510-01 | 1 VIAL in 1 CARTON (68083-510-01) / 1.5 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1.5GM/1.5ML (1GM/ML) | ||||
Approval Date: | Jul 6, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription